The MIROxi pulse oximeter is intended to be used by a physician or by a patient under the instruction of a physician or paramedic. The device is intended to test oximetry in people of all ages.

It can be used in any setting.

Device Description

MIROxi is a pulse oximeter, designed for use by specialist who require a simple, portable and compact device, yet at the same time being capable of calculating more than 30 statistical parameters derived from the SpO2 and pulse rate.

Its connectivity capability (USB, Bluetooth, internal modem for acoustic coupling to telephone, RS232) makes it suitable also for telemedicine applications.

AI/ML Overview

Here's a breakdown of the acceptance criteria and the study details for the MIROxi device, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria Category	Specific Criteria/Standard Adhered To	Reported Device Performance
Safety	EN 60601-1:1990 (Medical electrical equipment - Part 1: General requirements for safety)	"The results demonstrates that the device is in compliance with the standards referenced and that it performs within its specifications."
Environmental	EN 60601-1-2:1993 (Medical electrical equipment - Part 1-2: General requirements for safety - Collateral standard: Electromagnetic compatibility - Requirements and tests)	"The results demonstrates that the device is in compliance with the standards referenced and that it performs within its specifications."
Electromagnetic Compatibility (EMC)	Included under EN 60601-1-2:1993	"Testing was conducted in accordance with... EN 60601-1-2:1993. The results demonstrates that the device is in compliance..."
Electrical Durability	Not explicitly stated as a separate standard, but implied by EN 60601-1:1990 and general safety testing.	"electrical... testing have been completed. The results demonstrates that the device is in compliance with the standards referenced and that it performs within its specifications."
Mechanical Durability	Not explicitly stated as a separate standard, but implied by EN 60601-1:1990 and general safety testing.	"mechanical durability... testing have been completed. The results demonstrates that the device is in compliance with the standards referenced and that it performs within its specifications."
Safety (Operator and Patient)	Included under EN 60601-1:1990	"safety (operator and patient)... testing have been completed. The results demonstrates that the device is in compliance with the standards referenced and that it performs within its specifications."
Temperature/Humidity	Not explicitly stated as a separate standard, but implied by general environmental testing.	"temperature/humidity testing have been completed. The results demonstrates that the device is in compliance with the standards referenced and that it performs within its specifications."
SpO2 Accuracy	Not explicitly stated as a numerical criterion, but evaluated by "in vitro testing using an optical simulator, under normal conditions."	"The results obtained were within the specification."
Pulse Rate Accuracy	Not explicitly stated as a numerical criterion, but evaluated by "in vitro testing using an optical simulator, under normal conditions."	"The results obtained were within the specification."

2. Sample Size Used for the Test Set and Data Provenance

The provided text does not specify the sample size used for the test set or the data provenance (e.g., country of origin, retrospective/prospective). The accuracy validation mentions "in vitro testing using an optical simulator," which means the testing was conducted in a laboratory setting, not on human subjects or clinical data.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

Given that the accuracy validation was "in vitro testing using an optical simulator," there were no human experts used to establish ground truth for the SpO2 and pulse rate measurements. The optical simulator itself served as the "ground truth" by providing known, precise optical signals corresponding to specific SpO2 and pulse rate values.

4. Adjudication Method for the Test Set

Not applicable, as the ground truth for accuracy was established by an optical simulator, not human assessment.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No, a multi-reader multi-case (MRMC) comparative effectiveness study was not conducted. This type of study typically involves human readers assessing medical images or data with and without AI assistance to measure the AI's impact on human performance. The MIROxi device is a pulse oximeter, not an imaging device, and the testing described is focused on the device's standalone accuracy, not on its assistance to human interpretations.

6. Standalone (i.e., algorithm only without human-in-the-loop performance) Performance

Yes, a standalone performance evaluation was conducted. The accuracy of SpO2 and pulse rate was "validated by in vitro testing using an optical simulator, under normal conditions." This testing assessed the device's ability to accurately measure these parameters independently, without human interaction influencing the measurement process (beyond operating the device and simulator).

7. Type of Ground Truth Used

For the SpO2 and pulse rate accuracy measurements, the ground truth used was established by an optical simulator. This is a calibrated instrument that can generate precise optical signals corresponding to known physiological parameters.

8. Sample Size for the Training Set

The provided text does not mention or specify any training set sample size. Given the nature of a pulse oximeter (which relies on established physiological principles and optical absorbance), it's highly probable that a "training set" in the machine learning sense was not applicable or explicitly documented for this type of device. The device likely relies on a fixed algorithm embedded based on known physics and physiological models, rather than a machine learning model trained on a dataset.

9. How Ground Truth for the Training Set Was Established

As no training set is mentioned or implies to be used in the machine learning sense, this question is not applicable. The device's underlying principles are based on established scientific understanding of light absorption by oxygenated and deoxygenated hemoglobin.

Summary

{0}------------------------------------------------

Kof1033

Image /page/0/Picture/1 description: The image shows the logo for Medical International Research (MIR). The logo consists of a stylized, interconnected "M" shape above the letters "MIR" in bold, sans-serif font. Below the logo, the full name "MEDICAL INTERNATIONAL RESEARCH" is written in a smaller, sans-serif font.

JAN 1 5 2009

510(k) Summary

1. Applicant Information

Date Prepared:	January 25, 2007
Submitter:	MIR Medical International Research
Address:	Via del Maggiolino, 12500155 Roma - Italy
Contact Person:	Simon Fowler
Phone Number:	+39 06.22.754.777

2. Device Information

MIROxi Trade Name: Classification Name: Oximeter

3. Identification of legally marketed device to which the submitter claims equivalence:

Company Name:	MIR
Device Name:	Spirobank II
510(k) number:	K061712

4. Description of the device:

Its connectivity capability (USB, Bluetooth, internal modem for acoustic coupling to telephone, RS232) makes it suitable also for telemedicine applications.

5. Statement of Intended Use:

The MIROxi pulse oximeter is intended to be used by a physician or by a patient under the instruction of a physician or paramedic. The device is intended to test oximetry in people of all ages.

It can be used in any setting

6. Summary of the technological characteristics of the new device in comparison to those of the predicate device:

MIROxi is directly derived from the Spirobank II. Whereas Spirobank II performs both spirometry and oximetry, MIROxi performs only oximetry testing.

MIROxi uses the same oximetry board and oximetry sensors as the predicate device, and it also calculates the same statistical parameters (derived from the SpO2 and pulse rate).

{1}------------------------------------------------

7. Brief discussion of the clinical and nonclinical tests relied on for a determination of SE.

Testing was done to ensure that the MIROxy would perform safely and accurately within the environments for which it is to be marketed.

Safety and environmental testing was conducted in accordance with EN 60601-1:1990 and EN 60601-1-2:1993. Electromagnetic compatibility (EMC), electrical, mechanical durability, safety (operator and patient), and temperature/humidity testing have been completed. The results demonstrates that the device is in compliance with the standards referenced and that it performs within its specifications.

The accuracy of SpO2 and pulse rate has been validated by in vitro testing using an optical simulator, under normal conditions.

The results obtained were within the specification.

8. Conclusions

Based on these results, it is our determination that the device is safe, effective, and performs as well as the legally marketed device.

This summary on 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

{2}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with its wings spread, symbolizing the department's mission to protect the health of all Americans. The logo is black and white.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr Simon Fowler Sales Manager MIR Medical International Research Via del Maggiolino, 125 Roma ITALY 00155

JAN 1 5 2009

Re: K081033

Trade/Device Name: MIROxi Regulation Number: 21 CFR 870.2700 Regulation Name: Oximeter Regulatory Class: II Product Code: DQA Dated: December 17, 2008 Received: December 23, 2008

Dear Mr Fowler:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting vour device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register

{3}------------------------------------------------

Page 2 - Mr. Fowler

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described m your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Southe H. Michie Cunts.

Ginette Y. Michaud, M.D. Acting Division Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

():

{4}------------------------------------------------

Indications for Use

510(k) Number (K ).

Device Name: MIROxi

Indications for Use: The MIROxi pulse oximeter is intended to be used by a physician or by a patient under the instruction of a physician or paramedic. The device is intended to test oximetry in people of all ages.

It can be used in any setting.

Prescription Use × (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

And D. Dold

Page 1 of 1

(Division Sign Division of Anesthesiology. General Hospital Infection Control, Dental Devices

510(k) Number

Regulation Number and Section

§ 870.2700 Oximeter.

(a)
Identification. An oximeter is a device used to transmit radiation at a known wavelength(s) through blood and to measure the blood oxygen saturation based on the amount of reflected or scattered radiation. It may be used alone or in conjunction with a fiberoptic oximeter catheter.(b)
Classification. Class II (performance standards).